Walleye Trading’s Intersect ENT, Inc XENT Stock Holding History

Walleye Trading’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-600	Closed	-$7K	–	4762
2020 Q1	$7K	Buy	+600	New	+$13.3K	﹤0.01%	3776

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Walleye Trading's XENT Position: Q4 2020 in Review

Walleye Trading sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 4,233 shares — an estimated $80.6K sold.

Walleye Trading first reported a position in XENT in Q1 2020 and held it in 2 quarters. The position peaked at $289K in Q1 2020. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

Walleye Trading reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 4,233 Intersect ENT, Inc shares in Q4 2020, an estimated $80.6K.
Walleye Trading first reported a position in Intersect ENT, Inc in Q1 2020 and held it in 2 quarters.
Walleye Trading's Intersect ENT, Inc position peaked at $289K in Q1 2020.
110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.